AGP Picks
View all

My Healthcare Reporter
Provided by AGP

My Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on October 28, 2026

Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia
Oct. 28, 2026

Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia

Indeterminate GlobeNewswire
Beyond the Ballot: More Than 3,500 Back OHIP Petition as Psychotherapy Gaps Come Into Focus
Oct. 28, 2026

Beyond the Ballot: More Than 3,500 Back OHIP Petition as Psychotherapy Gaps Come Into Focus

Indeterminate GlobeNewswire
Canadian Vaping Association Says Flavour Bans Are a Gift to the Illicit Market
Oct. 28, 2026

Canadian Vaping Association Says Flavour Bans Are a Gift to the Illicit Market

Indeterminate GlobeNewswire
Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement
Oct. 28, 2026

Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement

Indeterminate GlobeNewswire
Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
Oct. 28, 2026

Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program

Indeterminate GlobeNewswire
Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets
Oct. 28, 2026

Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets

Indeterminate GlobeNewswire
Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026
Oct. 28, 2026

Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026

Indeterminate GlobeNewswire
15-year-old Designs Low-Cost Device to Monitor Airborne Bacteria in the Environment; Wins $25,000 Top Award at the 2026 Thermo Fisher Scientific Junior Innovators Challenge
Oct. 28, 2026

15-year-old Designs Low-Cost Device to Monitor Airborne Bacteria in the Environment; Wins $25,000 Top Award at the 2026 Thermo Fisher Scientific Junior Innovators Challenge

Indeterminate GlobeNewswire
Newsweek Places KFSH in Top 4% of World's Smart Hospitals for Digital Maturity and AI
Oct. 28, 2026

Newsweek Places KFSH in Top 4% of World's Smart Hospitals for Digital Maturity and AI

Indeterminate GlobeNewswire
Latest Data of Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2026
Oct. 28, 2026

Latest Data of Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

My Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.